These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34680348)

  • 1. Current Management of Oligometastatic Lung Cancer and Future Perspectives: Results of Thermal Ablation as a Local Ablative Therapy.
    Ghosn M; Solomon SB
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer.
    Kim C; Hoang CD; Kesarwala AH; Schrump DS; Guha U; Rajan A
    J Thorac Oncol; 2017 Feb; 12(2):179-193. PubMed ID: 27780780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local Thermal Ablation with Continuous EGFR Tyrosine Kinase Inhibitors for EGFR-Mutant Non-small Cell Lung Cancers that Developed Extra-Central Nervous System (CNS) Oligoprogressive Disease.
    Ni Y; Liu B; Ye X; Fan W; Bi J; Yang X; Huang G; Li W; Wang J; Han X; Wei Z; Meng M
    Cardiovasc Intervent Radiol; 2019 May; 42(5):693-699. PubMed ID: 30701290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Ablative Therapies in Oligometastatic NSCLC: New Data and New Directions.
    Lang P; Gomez DR; Palma DA
    Semin Respir Crit Care Med; 2020 Jun; 41(3):369-376. PubMed ID: 32450591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Image-Guided Thermal Lung Ablation: Society Guidelines, Therapeutic Alternatives, and Postablation Imaging Findings.
    Murphy MC; Wrobel MM; Fisher DA; Cahalane AM; Fintelmann FJ
    AJR Am J Roentgenol; 2022 Sep; 219(3):471-485. PubMed ID: 35319908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors.
    Rangamuwa K; Leong T; Weeden C; Asselin-Labat ML; Bozinovski S; Christie M; John T; Antippa P; Irving L; Steinfort D
    Transl Lung Cancer Res; 2021 Jun; 10(6):2842-2857. PubMed ID: 34295682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.
    Petre EN; Sofocleous C
    Visc Med; 2017 Mar; 33(1):62-68. PubMed ID: 28612019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local ablative therapies in oligometastatic NSCLC-upfront or outback?-a narrative review.
    Tjong MC; Louie AV; Iyengar P; Solomon BJ; Palma DA; Siva S
    Transl Lung Cancer Res; 2021 Jul; 10(7):3446-3456. PubMed ID: 34430379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic ablative body radiation for oligometastatic and oligoprogressive disease.
    Ning MS; Gomez DR; Heymach JV; Swisher SG
    Transl Lung Cancer Res; 2019 Feb; 8(1):97-106. PubMed ID: 30788239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Strategies for Oligometastatic Breast Cancer.
    Nesbit EG; Donnelly ED; Strauss JB
    Curr Treat Options Oncol; 2021 Aug; 22(10):94. PubMed ID: 34426881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer: Theory and Practice.
    Rusthoven CG; Yeh N; Gaspar LE
    Cancer J; 2015; 21(5):404-12. PubMed ID: 26389766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung ablation: Best practice/results/response assessment/role alongside other ablative therapies.
    de Baere T; Tselikas L; Gravel G; Deschamps F
    Clin Radiol; 2017 Aug; 72(8):657-664. PubMed ID: 28215455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Ablative Therapies for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer.
    Jairam V; Park HS; Decker RH
    Cancer J; 2020; 26(2):129-136. PubMed ID: 32205537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
    Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
    Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation.
    Loveman E; Jones J; Clegg AJ; Picot J; Colquitt JL; Mendes D; Breen DJ; Moore E; George S; Poston G; Cunningham D; Ruers T; Primrose J
    Health Technol Assess; 2014 Jan; 18(7):vii-viii, 1-283. PubMed ID: 24484609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous image-guided thermal ablation of lung cancer: What is the evidence?
    Bartlett EC; Rahman S; Ridge CA
    Lung Cancer; 2023 Feb; 176():14-23. PubMed ID: 36571982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of thermal ablation in the management of colorectal liver metastasis.
    Takahashi H; Berber E
    Hepatobiliary Surg Nutr; 2020 Feb; 9(1):49-58. PubMed ID: 32140478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Percutaneous Image-Guided Microwave Ablation and Cryoablation for Sarcoma Lung Metastases: A 10-Year Experience.
    Bourgouin PP; Wrobel MM; Mercaldo ND; Murphy MC; Leppelmann KS; Levesque VM; Muniappan A; Silverman SG; Shepard JO; Shyn PB; Fintelmann FJ
    AJR Am J Roentgenol; 2022 Mar; 218(3):494-504. PubMed ID: 34612679
    [No Abstract]   [Full Text] [Related]  

  • 19. Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study.
    Ni Y; Bi J; Ye X; Fan W; Yu G; Yang X; Huang G; Li W; Wang J; Han X; Ni X; Wei Z; Han M; Zheng A; Meng M; Xue G; Zhang L; Wan C
    Medicine (Baltimore); 2016 Jun; 95(25):e3998. PubMed ID: 27336903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Juan O; Popat S
    Clin Lung Cancer; 2017 Nov; 18(6):595-606. PubMed ID: 28377206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.